Resumo

FERRER MERCADO, César et al. Hemoperfusion with the Cytosorb device in a patient with severe COVID-19. Rev. colom. nefrol. [online]. 2021, vol.8, n.1, e402.  Epub 22-Out-2021. ISSN 2500-5006.  https://doi.org/10.22265/acnef.8.1.515.

The COVID-19 disease is an infectious disease caused by the SARS-CoV 2 virus whose clinical presentation is very heterogeneous: it can range from asymptomatic people to critically ill patients, with cytokine storm, acute respiratory distress, organ dysfunction and even death. Current therapies for its treatment are aimed at reducing the impact of the inflammatory cascade, and within these we find hemoadsorption technologies such as the CytoSorb membrane. Next, we present a 31-year-old male patient, who consulted due to severe symptoms of COVID-19 and showed an evident clinical and biochemical improvement after using the CytoSorb device. This is the only documented patient in Colombia who has undergone haemoperfusion therapy with this device in conjunction with prolonged intermittent renal replacement therapy and favorable clinical outcomes have been recorded.

Palavras-chave : Acute Kidney Injury; COVID-19; Hemoperfusion..

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )